These data indicate that PSMD1 and PSMD3 promote UPS-dependent NF-κB activation in CML, and suggest that other factors are responsible for further activating NF-κB during TKI resistance. This evidence concerns the gene PSMD1 and chronic myelogenous leukemia, BCR-ABL1 positive.